- Home
- VLY vs KYMR Comparison
VLY vs KYMR Comparison
Compare VLY & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLY
- KYMR
- Stock Information
- Founded
- VLY 1927
- KYMR 2015
- Country
- VLY United States
- KYMR United States
- Employees
- VLY N/A
- KYMR N/A
- Industry
- VLY Major Banks
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- VLY Finance
- KYMR Health Care
- Exchange
- VLY Nasdaq
- KYMR Nasdaq
- Market Cap
- VLY 5.2B
- KYMR 4.3B
- IPO Year
- VLY N/A
- KYMR 2020
- Fundamental
- Price
- VLY $10.93
- KYMR $59.89
- Analyst Decision
- VLY Buy
- KYMR Strong Buy
- Analyst Count
- VLY 15
- KYMR 19
- Target Price
- VLY $12.80
- KYMR $68.95
- AVG Volume (30 Days)
- VLY 15.4M
- KYMR 683.2K
- Earning Date
- VLY 10-23-2025
- KYMR 11-04-2025
- Dividend Yield
- VLY 4.03%
- KYMR N/A
- EPS Growth
- VLY 40.78
- KYMR N/A
- EPS
- VLY 0.88
- KYMR N/A
- Revenue
- VLY $1,704,193,000.00
- KYMR $43,735,000.00
- Revenue This Year
- VLY $33.72
- KYMR $60.88
- Revenue Next Year
- VLY $10.10
- KYMR N/A
- P/E Ratio
- VLY $12.43
- KYMR N/A
- Revenue Growth
- VLY 8.06
- KYMR N/A
- 52 Week Low
- VLY $7.48
- KYMR $19.45
- 52 Week High
- VLY $11.35
- KYMR $63.96
- Technical
- Relative Strength Index (RSI)
- VLY 55.26
- KYMR 55.68
- Support Level
- VLY $10.67
- KYMR $55.66
- Resistance Level
- VLY $10.93
- KYMR $63.36
- Average True Range (ATR)
- VLY 0.35
- KYMR 3.13
- MACD
- VLY 0.03
- KYMR -0.37
- Stochastic Oscillator
- VLY 74.39
- KYMR 57.16
About VLY Valley National Bancorp
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.